10-year data shows accuray cyberknife® system provides long-lasting relief of the excruciating pain caused by trigeminal neuralgia

Study abstract recognized as best clinical abstract at 2022 radiosurgical society meeting sunnyvale, calif. , march 31, 2022 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (tn) showed 72 percent continued to experience pain relief 10 years after receiving image-guided robotic radiosurgery treatments delivered with the cyberknife ® system.
ARAY Ratings Summary
ARAY Quant Ranking